There are 3 PARP inhibitors that are FDA approved in multiple settings of ovarian cancer.
Britny Rogala, PharmD, BCOP
Advertisement
Articles by Britny Rogala, PharmD, BCOP
Advertisement
Latest Updated Articles
Overview of PARP Inhibitors in the Treatment of Ovarian CancerPublished: October 11th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
2
FDA Approves Gazyva for Active Lupus Nephritis
3
Amivantamab Shows 45% Response Rate in Pretreated Head and Neck Cancer: OrigAMI-4 Findings
4
KEYNOTE-755 Confirms Broad Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer
5
